2,6-dichlorophenylacetonitrile

from Wikipedia, the free encyclopedia
Structural formula
Structural formula of 2,6-dichlorophenylacetonitrile
General
Surname 2,6-dichlorophenylacetonitrile
other names

2,6-dichlorobenzyl cyanide

Molecular formula C 8 H 5 Cl 2 N
Brief description

off-white crystal powder

External identifiers / databases
CAS number 3215-64-3
EC number 221-730-8
ECHA InfoCard 100,019,755
PubChem 76678
ChemSpider 69139
Wikidata Q72467273
properties
Molar mass 186.04 g mol −1
Physical state

firmly

density

1.4274 g cm −3 at 20 ° C

Melting point

74-77 ° C

solubility

in methanol

Refractive index

1.5690 (25 ° C, 589 nm)

safety instructions
GHS labeling of hazardous substances
07 - Warning

Caution

H and P phrases H: 335-315-319-312-302-332
P: 261-280-301 + 312-302 + 352-304 + 340-305 + 351 + 338
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . Refractive index: Na-D line , 20 ° C

2,6-dichlorophenylacetonitrile is a substituted acetonitrile which has a phenyl group substituted in the 2- and in the 6-position by a chlorine atom . The compound is the starting material for chemical intermediates and pharmaceuticals , such as. B. guanfacine , from the group of antisympathotonics , which is also used in particular for the treatment of attention deficit / hyperactivity disorder ADHD.

Manufacturing

The production of 2,6-dichlorophenylacetonitrile proceeds in the sense of a Kolbe nitrile synthesis , 2,6-dichlorobenzyl chloride (by chlorination of 2,6-dichlorotoluene according to the SSS rule ) with alkali cyanides, such as. B. potassium cyanide is implemented in the presence of the phase transfer catalyst 18-crown-6 (yield 95%).

Synthesis of 2,6-dichlorophenylacetonitrile

properties

2,6-dichlorophenylacetonitrile is a white, odorless solid that dissolves in alcohols such as. B. methanol, dissolves.

Applications

The reduction (chemistry) of 2,6-dichlorobenzyl cyanide with diisobutylaluminum hydride DIBAL provides 2,6-dichlorophenylacetaldehyde in useful yields as the starting material for the herbicide diclobenil, which is no longer approved in the EU .

Synthesis of 2,6-dichlorophenylacetaldehyde

With 2,6-dichlorophenylacetonitrile as a starting material, fused bicyclic heteroaromatics were prepared which, like z. B. the substituted pyrazolo [1,5-a] pyrimidin-2-ones as pharmaceutical active ingredients against autoimmune diseases and cancer , as well as the derivatives of the diazanaphthalene 1,6-naphthyridin-2 (1 H ) -one as tyrosine kinase inhibitors were investigated.

Bicyclic heteroaromatics from 2,6-dichlorophenylacetonitrile

The most important use of 2,6-dichlorophenylacetonitrile is as starting material for the ADHD therapeutic guanfacine . To do this, the nitrile is first converted into the corresponding ethyl ester and reacted with guanidine at room temperature. The product 2,6-dichlorophenylacetylguanidine is obtained in about 70% yield.

Synthesis of guanfacine via ethyl ester

Alternatively, 2,6-dichlorophenylacetonitrile is first formylated with ethyl formate on the activated methylene group and then reacted with guanidine hydrochloride to give α- (guanidinomethylene) -2,6-dichlorophenylacetonitrile. The cyano group is split off and rearranged to form 2,6-dichlorophenylacetylguanidine hydrochloride by boiling with dilute hydrochloric acid.

Synthesis of guanfacine via formyl compound

Individual evidence

  1. a b c d data sheet 2,6-dichlorophenylacetonitrile from AlfaAesar, accessed on November 28, 2019 ( PDF )(JavaScript required) .
  2. ^ A b Carl L. Yaws: Thermophysical Properties of Chemicals and Hydrocarbons, 2nd Edition . Elsevier Inc., Oxford, UK 2015, ISBN 978-0-323-28659-6 , pp. 179 .
  3. Entry on 2,6-dichlorobenzyl cyanide at TCI Europe, accessed on November 28, 2019.
  4. a b Patent WO200705866A2 : Inhibitors of P30 kinase and methods of treating inflammatory disorders. Filed July 18, 2006 , published February 8, 2007 , Applicant: Kalypsys, Inc., Inventors: DL Severance, AJ Borchardt, EMM Gardiner, M. Kahraman.
  5. patent US20190330157A1 : Therapeutic compounds. Filed June 3, 2019 , published October 31, 2019 , applicant: Regents of the University of Minnesota, inventor: SS More, R. Vince.
  6. AM Thompson, GW Rewcastle, SL Boushelle, BG Hartl, AJ Kraker, GH Lu, BL Batley, RL Panek, HD Showalter, WA Denny: Synthesis and structure-activity relationships of 7-substituted 3- (2,6-dichlorophenyl) -1,6-naphthyridin-2 (1 H ) -ones as selective inhibitors of pp60 (c-src) . In: J. Med. Chem. Volume 43 , no. 16 , 2000, pp. 3134-3147 , doi : 10.1021 / jm000148t .
  7. Patent CH479559 : Process for the production of acylguanidines. Applied on September 26, 1967 , published November 28, 1969 , applicant: Dr. A. Wander AG, inventor: JB Bream, CW Picard.
  8. Patent CH511816 : Process for the production of acylguanidines. Applied on February 26, 1967 , published October 15, 1971 , applicant: Dr. A. Wander AG, inventor: JB Bream, CW Picard.